The role of cell-free DNA in cancer treatment decision making

A Telekes, A Horváth - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to evaluate the present status of the use of cell-
free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an …

[HTML][HTML] Exercise as cancer treatment: A clinical oncology framework for exercise oncology research

KS Courneya, CM Booth - Frontiers in oncology, 2022 - frontiersin.org
Exercise has been proposed as a possible cancer treatment; however, there are an infinite
number of clinical oncology settings involving diverse cancer types and treatment protocols …

Antigen retrieval assisted electrochemiluminescence imaging of surface antigens at single tissue section

C Fu, D Han, D Jiang, D Jiang - Electrochimica Acta, 2024 - Elsevier
Previously, our group has established an electrochemiluminescence (ECL) molecular
imaging method to detect carcinoembryonic antigen (CEA) at single tissue sections of …

Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies

H Filali, OM El Yaagoubi, A Lahmadi, A Quessar… - Clinical Proteomics, 2022 - Springer
Background Regulatory degradation of intracellular proteins plays an essential role in most
biological processes, particularly in the control of cell proliferation and differentiation. In …

Implementing and assessing Bayesian response-adaptive randomisation for backfilling in dose-finding trials

L Pin, SS Villar, HM Dehbi - Contemporary Clinical Trials, 2024 - Elsevier
Traditional approaches in dose-finding trials, such as the continual reassessment method,
focus on identifying the maximum tolerated dose. In contemporary early-phase dose-finding …

Microbiome and Metabolomic Biomarkers for Huntington's Disease

BA Masson, W Qin, CJ Love, C Gubert… - … for Huntington's Disease …, 2023 - Springer
Huntington's disease (HD) is a fatal monogenic neurodegenerative disorder caused by the
expansion of the trinucleotide tandem repeat in the huntingtin (HTT) gene. This results in …

Potential role of tumor-derived exosomes in non-small-cell lung cancer in the era of immunotherapy

A Tartarone, R Lerose, M Tartarone, M Aieta - Life, 2022 - mdpi.com
Lung cancer, of which non-small-cell lung cancer (NSCLC) represents about 80% of all
cases, is the second most common cancer diagnosed in the general population and one of …

Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker …

Y Bi, C Xia, X Zhang, H Liu - Oncology Letters, 2023 - spandidos-publications.com
Ongoing investigations of targeted therapeutic agents and their increased clinical
applications, together with research in genomics and proteomics, have explored a variety of …